Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 217

1.

Immunogenicity of high-dose influenza vaccination in patients with primary central nervous system malignancy.

Strowd RE, Russell G, Hsu FC, Carter AF, Chan M, Tatter SB, Laxton AW, Alexander-Miller MA, High K, Lesser GJ.

Neurooncol Pract. 2018 Aug;5(3):176-183. doi: 10.1093/nop/npx035. Epub 2018 Jan 6.

2.

A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma.

Wen PY, Reardon DA, Armstrong TS, Phuphanich S, Aiken RD, Landolfi JC, Curry WT, Zhu JJ, Glantz M, Peereboom DM, Markert JM, LaRocca R, O'Rourke DM, Fink K, Kim L, Gruber M, Lesser GJ, Pan E, Kesari S, Muzikansky A, Pinilla C, Santos RG, Yu JS.

Clin Cancer Res. 2019 Jul 18. doi: 10.1158/1078-0432.CCR-19-0261. [Epub ahead of print]

PMID:
31320597
3.

Genome-wide enriched pathway analysis of acute post-radiotherapy pain in breast cancer patients: a prospective cohort study.

Lee E, Takita C, Wright JL, Slifer SH, Martin ER, Urbanic JJ, Langefeld CD, Lesser GJ, Shaw EG, Hu JJ.

Hum Genomics. 2019 Jun 13;13(1):28. doi: 10.1186/s40246-019-0212-8.

4.

Treatment of Radiation-Induced Cognitive Decline in Adult Brain Tumor Patients.

Cramer CK, Cummings TL, Andrews RN, Strowd R, Rapp SR, Shaw EG, Chan MD, Lesser GJ.

Curr Treat Options Oncol. 2019 Apr 8;20(5):42. doi: 10.1007/s11864-019-0641-6. Review.

PMID:
30963289
5.

Postoperative Complications of Ab Interno Gelatin Microstent.

Rooney DM, Shadid HR, Siegel LI, Watnick RL, Lesser GR, Obertynski T, Siegel MJ, Citron ME, Hasbrook M, Siegel MJ.

J Glaucoma. 2019 May;28(5):e77-e81. doi: 10.1097/IJG.0000000000001194.

PMID:
30676413
6.

Safety of pioglitazone during and after radiation therapy in patients with brain tumors: a phase I clinical trial.

Cramer CK, Alphonse-Sullivan N, Isom S, Metheny-Barlow LJ, Cummings TL, Page BR, Brown DR, Blackstock AW Jr, Peiffer AM, Strowd RE, Rapp S, Lesser GJ, Shaw EG, Chan MD.

J Cancer Res Clin Oncol. 2019 Feb;145(2):337-344. doi: 10.1007/s00432-018-2791-5. Epub 2018 Nov 12.

PMID:
30417218
7.

Mild cognitive impairment in long-term brain tumor survivors following brain irradiation.

Cramer CK, McKee N, Case LD, Chan MD, Cummings TL, Lesser GJ, Shaw EG, Rapp SR.

J Neurooncol. 2019 Jan;141(1):235-244. doi: 10.1007/s11060-018-03032-8. Epub 2018 Nov 7.

8.

Effect of lactoferrin on taste and smell abnormalities induced by chemotherapy: a proteome analysis.

Wang A, Duncan SE, Lesser GJ, Ray WK, Dietrich AM.

Food Funct. 2018 Sep 19;9(9):4948-4958. doi: 10.1039/c8fo00813b.

PMID:
30182113
9.

Glioblastoma radiomics: can genomic and molecular characteristics correlate with imaging response patterns?

Soike MH, McTyre ER, Shah N, Puchalski RB, Holmes JA, Paulsson AK, Miller LD, Cramer CK, Lesser GJ, Strowd RE, Hinson WH, Mott RT, Johnson AJ, Lo HW, Laxton AW, Tatter SB, Debinski W, Chan MD.

Neuroradiology. 2018 Oct;60(10):1043-1051. doi: 10.1007/s00234-018-2060-y. Epub 2018 Aug 10.

PMID:
30094640
10.

Hypoxia-inducible factor 2α: a novel target in gliomas.

Renfrow JJ, Soike MH, Debinski W, Ramkissoon SH, Mott RT, Frenkel MB, Sarkaria JN, Lesser GJ, Strowd RE.

Future Med Chem. 2018 Sep 1;10(18):2227-2236. doi: 10.4155/fmc-2018-0163. Epub 2018 Aug 9. Review.

11.

Association Between Inflammatory Biomarker C-Reactive Protein and Radiotherapy-Induced Early Adverse Skin Reactions in a Multiracial/Ethnic Breast Cancer Population.

Hu JJ, Urbanic JJ, Case LD, Takita C, Wright JL, Brown DR, Langefeld CD, Lively MO, Mitchell SE, Thakrar A, Bryant D, Baglan K, Strasser J, Baez-Diaz L, Lesser GJ, Shaw EG.

J Clin Oncol. 2018 Aug 20;36(24):2473-2482. doi: 10.1200/JCO.2017.77.1790. Epub 2018 Jul 10.

12.

Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide: An Analysis From the NRG Oncology/RTOG 0424 Trial.

Bell EH, Zhang P, Fisher BJ, Macdonald DR, McElroy JP, Lesser GJ, Fleming J, Chakraborty AR, Liu Z, Becker AP, Fabian D, Aldape KD, Ashby LS, Werner-Wasik M, Walker EM, Bahary JP, Kwok Y, Yu HM, Laack NN, Schultz CJ, Gray HJ, Robins HI, Mehta MP, Chakravarti A.

JAMA Oncol. 2018 Oct 1;4(10):1405-1409. doi: 10.1001/jamaoncol.2018.1977.

13.

Precision Neuro-oncology: the Role of Genomic Testing in the Management of Adult and Pediatric Gliomas.

Ramkissoon LA, Britt N, Guevara A, Whitt E, Severson E, Sathyan P, Gay L, Elvin J, Ross JS, Brown C, Stogner-Underwood K, Mott R, Kram D, Strowd R, Lesser GJ, Ramkissoon SH.

Curr Treat Options Oncol. 2018 Jun 21;19(8):41. doi: 10.1007/s11864-018-0559-4. Review.

PMID:
29931654
14.

Self-reported adherence and biomarker levels of CoQ10 and alpha-tocopherol.

Vitolins MZ, Case LD, Rapp SR, Lively MO, Shaw EG, Naughton MJ, Giguere J, Lesser GJ.

Patient Prefer Adherence. 2018 Apr 24;12:637-646. doi: 10.2147/PPA.S158682. eCollection 2018.

15.

Truncated Glioma-Associated Oncogene Homolog 1 (tGLI1) Mediates Mesenchymal Glioblastoma via Transcriptional Activation of CD44.

Rimkus TK, Carpenter RL, Sirkisoon S, Zhu D, Pasche BC, Chan MD, Lesser GJ, Tatter SB, Watabe K, Debinski W, Lo HW.

Cancer Res. 2018 May 15;78(10):2589-2600. doi: 10.1158/0008-5472.CAN-17-2933. Epub 2018 Feb 20.

16.

Stereotactic radiosurgery in the treatment of brain metastases from gynecologic primary cancer.

Johnston H, McTyre ER, Cramer CK, Lesser GJ, Ruiz J, Bourland JD, Watabe K, Lo HW, Qasem S, Laxton AW, Tatter SB, Chan MD.

J Radiosurg SBRT. 2017;5(1):55-61.

17.

Hyperglycemia during first-line R-CHOP or dose adjusted R-EPOCH chemotherapy for non-Hodgkin lymphoma is prevalent and associated with chemotherapy alteration - a retrospective study.

Lamar ZS, Dothard A, Kennedy L, Isom S, Robinson M, Vaidya R, Hurd D, McClain D, Lesser G.

Leuk Lymphoma. 2018 Aug;59(8):1871-1877. doi: 10.1080/10428194.2017.1410889. Epub 2017 Dec 18.

18.

Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02.

Galanis E, Anderson SK, Miller CR, Sarkaria JN, Jaeckle K, Buckner JC, Ligon KL, Ballman KV, Moore DF Jr, Nebozhyn M, Loboda A, Schiff D, Ahluwalia MS, Lee EQ, Gerstner ER, Lesser GJ, Prados M, Grossman SA, Cerhan J, Giannini C, Wen PY; Alliance for Clinical Trials in Oncology and ABTC.

Neuro Oncol. 2018 Mar 27;20(4):546-556. doi: 10.1093/neuonc/nox161.

19.

Use of non-ionizing electromagnetic fields for the treatment of cancer.

Jimenez H, Blackman C, Lesser G, Debinski W, Chan M, Sharma S, Watabe K, Lo HW, Thomas A, Godwin D, Blackstock W, Mudry A, Posey J, O'Connor R, Brezovich I, Bonin K, Kim-Shapiro D, Barbault A, Pasche B.

Front Biosci (Landmark Ed). 2018 Jan 1;23:284-297. Review.

PMID:
28930547
20.

Comprehensive Genomic Profiling of 282 Pediatric Low- and High-Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation Signatures.

Johnson A, Severson E, Gay L, Vergilio JA, Elvin J, Suh J, Daniel S, Covert M, Frampton GM, Hsu S, Lesser GJ, Stogner-Underwood K, Mott RT, Rush SZ, Stanke JJ, Dahiya S, Sun J, Reddy P, Chalmers ZR, Erlich R, Chudnovsky Y, Fabrizio D, Schrock AB, Ali S, Miller V, Stephens PJ, Ross J, Crawford JR, Ramkissoon SH.

Oncologist. 2017 Dec;22(12):1478-1490. doi: 10.1634/theoncologist.2017-0242. Epub 2017 Sep 14.

21.

Enhancing Irreversible Electroporation by Manipulating Cellular Biophysics with a Molecular Adjuvant.

Ivey JW, Latouche EL, Richards ML, Lesser GJ, Debinski W, Davalos RV, Verbridge SS.

Biophys J. 2017 Jul 25;113(2):472-480. doi: 10.1016/j.bpj.2017.06.014.

22.

Surgical Considerations in the Optimal Management of Patients with Malignant Brain Tumors.

Renfrow JJ, Strowd RE, Laxton AW, Tatter SB, Geer CP, Lesser GJ.

Curr Treat Options Oncol. 2017 Aug;18(8):46. doi: 10.1007/s11864-017-0487-8. Review.

PMID:
28681208
23.

Timed sequential therapy of the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomas.

Holdhoff M, Ye X, Supko JG, Nabors LB, Desai AS, Walbert T, Lesser GJ, Read WL, Lieberman FS, Lodge MA, Leal J, Fisher JD, Desideri S, Grossman SA, Wahl RL, Schiff D.

Neuro Oncol. 2017 Jun 1;19(6):845-852. doi: 10.1093/neuonc/nox020.

24.

Frequency of Left Ventricular End-Diastolic Volume-Mediated Declines in Ejection Fraction in Patients Receiving Potentially Cardiotoxic Cancer Treatment.

Meléndez GC, Sukpraphrute B, D'Agostino RB Jr, Jordan JH, Klepin HD, Ellis L, Lamar Z, Vasu S, Lesser G, Burke GL, Weaver KE, Ntim WO, Hundley WG.

Am J Cardiol. 2017 May 15;119(10):1637-1642. doi: 10.1016/j.amjcard.2017.02.008. Epub 2017 Mar 22.

25.

Outcomes for Anaplastic Glioma Treated With Radiation Therapy With or Without Concurrent Temozolomide.

McTyre E, Lucas JT, Helis C, Farris M, Soike M, Mott R, Laxton AW, Tatter SB, Lesser GJ, Strowd RE, Lo HW, Debinski W, Chan MD.

Am J Clin Oncol. 2018 Aug;41(8):813-819. doi: 10.1097/COC.0000000000000380.

PMID:
28301347
26.

A Randomized Double-Blind Placebo-Controlled Trial of Fruit and Vegetable Concentrates on Intermediate Biomarkers in Head and Neck Cancer.

Datta M, Shaw EG, Lesser GJ, Case LD, Vitolins MZ, Schneider C, Frizzell B, Sullivan C, Lively M, Franzmann E, Hu JJ.

Integr Cancer Ther. 2018 Mar;17(1):115-123. doi: 10.1177/1534735416684947. Epub 2017 Jan 19.

27.

National Institute on Aging /Alzheimer's Association criteria for Mild Cognitive Impairment applied to chemotherapy treated breast cancer survivors.

Gifford AR, Lawrence JA, Baker LD, Balcueva EP, Case D, Craft S, Curtis AE, Griffin L, Groteluschen DL, Klepin HD, Lesser GJ, Messino MJ, Naughton M, Samuel TA, Rapp S, Sachs B, Sink KM, Williamson J, Shaw EG.

J Oncol Research. 2017;1(1). pii: 101. Epub 2017 Oct 20.

28.

MMP19 expression in the human optic nerve.

Chirco KR, Hazlewood RJ, Miller K, Workalemahu G, Jampol LM, Lesser GR, Mullins RF, Kuehn MH, Fingert JH.

Mol Vis. 2016 Dec 14;22:1429-1436. eCollection 2016.

29.

Impact of timing of radiotherapy in patients with newly diagnosed glioblastoma.

Randolph DM 2nd, McTyre ER, Paulsson AK, Holmes JA, Hinson WH, Lesser GJ, Strowd R, Lo HW, Laxton AW, Tatter SB, Debinski W, Chan MD.

Clin Neurol Neurosurg. 2016 Dec;151:73-78. doi: 10.1016/j.clineuro.2016.10.012. Epub 2016 Oct 22.

PMID:
27816029
30.

Repeatability of 18F-FLT PET in a Multicenter Study of Patients with High-Grade Glioma.

Lodge MA, Holdhoff M, Leal JP, Bag AK, Nabors LB, Mintz A, Lesser GJ, Mankoff DA, Desai AS, Mountz JM, Lieberman FS, Fisher JD, Desideri S, Ye X, Grossman SA, Schiff D, Wahl RL.

J Nucl Med. 2017 Mar;58(3):393-398. doi: 10.2967/jnumed.116.178434. Epub 2016 Sep 29.

31.

Feasibility, phase I, and phase II studies of tandutinib, an oral platelet-derived growth factor receptor-β tyrosine kinase inhibitor, in patients with recurrent glioblastoma.

Batchelor TT, Gerstner ER, Ye X, Desideri S, Duda DG, Peereboom D, Lesser GJ, Chowdhary S, Wen PY, Grossman S, Supko JG.

Neuro Oncol. 2017 Apr 1;19(4):567-575. doi: 10.1093/neuonc/now185.

32.

Creating clinical trial designs that incorporate clinical outcome assessments.

Gilbert MR, Rubinstein L, Lesser G.

Neuro Oncol. 2016 Mar;18 Suppl 2:ii21-ii25. doi: 10.1093/neuonc/nov254. Review.

33.

Neglected Categorical Differences of Hypertension of the Elderly vs. the Young: A Case of Institutional Amnesia?

Lesser GT.

J Am Med Dir Assoc. 2016 May 1;17(5):376-8. doi: 10.1016/j.jamda.2016.02.013. Epub 2016 Mar 10. No abstract available.

PMID:
26972350
34.

Making the most of the imaging we have: using head MRI to estimate body composition.

Lack CM, Lesser GJ, Umesi UN, Bowns J, Chen MY, Case D, Hightower RC, Johnson AJ.

Clin Radiol. 2016 Apr;71(4):402.e1-7. doi: 10.1016/j.crad.2015.12.004. Epub 2016 Jan 12.

35.

Treatment of brain metastases of lung cancer in the era of precision medicine.

Haughton ME, Chan MD, Watabe K, Bonomi M, Debinski W, Lesser GJ, Ruiz J.

Front Biosci (Elite Ed). 2016 Jan 1;8:219-32.

PMID:
26709658
36.

Bevacizumab and Glioblastoma: The Ecstasy and the Agony.

Lesser GJ.

Oncology (Williston Park). 2015 Oct;29(10):728-9. No abstract available.

37.

Effect of ArginMax on sexual functioning and quality of life among female cancer survivors: results of the WFU CCOP Research Base Protocol 97106.

Greven KM, Case LD, Nycum LR, Zekan PJ, Hurd DD, Balcueva EP, Mills GM, Zon R, Flynn PJ, Biggs D, Shaw EG, Lesser G, Naughton MJ.

J Community Support Oncol. 2015 Mar;13(3):87-94. doi: 10.12788/jcso.0114.

38.

Genomic predictors of patterns of progression in glioblastoma and possible influences on radiation field design.

Holmes JA, Paulsson AK, Page BR, Miller LD, Liu W, Xu J, Hinson WH, Lesser GJ, Laxton AW, Tatter SB, Debinski W, Chan MD.

J Neurooncol. 2015 Sep;124(3):447-53. doi: 10.1007/s11060-015-1858-2. Epub 2015 Jul 18.

39.

A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy.

Lawrence JA, Griffin L, Balcueva EP, Groteluschen DL, Samuel TA, Lesser GJ, Naughton MJ, Case LD, Shaw EG, Rapp SR.

J Cancer Surviv. 2016 Feb;10(1):176-84. doi: 10.1007/s11764-015-0463-x. Epub 2015 Jul 1.

40.

Phase II double-blind placebo-controlled randomized study of armodafinil for brain radiation-induced fatigue.

Page BR, Shaw EG, Lu L, Bryant D, Grisell D, Lesser GJ, Monitto DC, Naughton MJ, Rapp SR, Savona SR, Shah S, Case D, Chan MD.

Neuro Oncol. 2015 Oct;17(10):1393-401. doi: 10.1093/neuonc/nov084. Epub 2015 May 12.

41.

Anaplastic ganglioglioma: a report of three cases and review of the literature.

Lucas JT Jr, Huang AJ, Mott RT, Lesser GJ, Tatter SB, Chan MD.

J Neurooncol. 2015 May;123(1):171-7. doi: 10.1007/s11060-015-1781-6. Epub 2015 Apr 11. Review.

42.

Phase 2 study of temozolomide-based chemoradiation therapy for high-risk low-grade gliomas: preliminary results of Radiation Therapy Oncology Group 0424.

Fisher BJ, Hu C, Macdonald DR, Lesser GJ, Coons SW, Brachman DG, Ryu S, Werner-Wasik M, Bahary JP, Liu J, Chakravarti A, Mehta M.

Int J Radiat Oncol Biol Phys. 2015 Mar 1;91(3):497-504. doi: 10.1016/j.ijrobp.2014.11.012. Epub 2015 Jan 30.

43.

Issues concerning sarcopenia in ageing adults.

Lesser GT.

Age Ageing. 2015 Mar;44(2):343. doi: 10.1093/ageing/afu207. Epub 2015 Jan 19. No abstract available.

PMID:
25600006
44.

Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma.

Norden AD, Ligon KL, Hammond SN, Muzikansky A, Reardon DA, Kaley TJ, Batchelor TT, Plotkin SR, Raizer JJ, Wong ET, Drappatz J, Lesser GJ, Haidar S, Beroukhim R, Lee EQ, Doherty L, Lafrankie D, Gaffey SC, Gerard M, Smith KH, McCluskey C, Phuphanich S, Wen PY.

Neurology. 2015 Jan 20;84(3):280-6. doi: 10.1212/WNL.0000000000001153. Epub 2014 Dec 19.

45.

Phase II trial of triple tyrosine kinase receptor inhibitor nintedanib in recurrent high-grade gliomas.

Norden AD, Schiff D, Ahluwalia MS, Lesser GJ, Nayak L, Lee EQ, Rinne ML, Muzikansky A, Dietrich J, Purow B, Doherty LM, LaFrankie DC, Pulverenti JR, Rifenburg JA, Ruland SF, Smith KH, Gaffey SC, McCluskey C, Ligon KL, Reardon DA, Wen PY.

J Neurooncol. 2015 Jan;121(2):297-302. doi: 10.1007/s11060-014-1631-y. Epub 2014 Oct 22.

PMID:
25338318
46.

Treatment of radiation-induced cognitive decline.

Attia A, Page BR, Lesser GJ, Chan M.

Curr Treat Options Oncol. 2014 Dec;15(4):539-50. doi: 10.1007/s11864-014-0307-3. Review.

PMID:
25228143
47.

Risk factors for leptomeningeal carcinomatosis in patients with brain metastases who have previously undergone stereotactic radiosurgery.

Huang AJ, Huang KE, Page BR, Ayala-Peacock DN, Lucas JT Jr, Lesser GJ, Laxton AW, Tatter SB, Chan MD.

J Neurooncol. 2014 Oct;120(1):163-9. doi: 10.1007/s11060-014-1539-6. Epub 2014 Jul 22.

PMID:
25048529
48.

Comparison of clinical outcomes and genomic characteristics of single focus and multifocal glioblastoma.

Paulsson AK, Holmes JA, Peiffer AM, Miller LD, Liu W, Xu J, Hinson WH, Lesser GJ, Laxton AW, Tatter SB, Debinski W, Chan MD.

J Neurooncol. 2014 Sep;119(2):429-35. doi: 10.1007/s11060-014-1515-1. Epub 2014 Jul 3.

49.

Taste and smell disturbances after brain irradiation: a dose-volume histogram analysis of a prospective observational study.

Leyrer CM, Chan MD, Peiffer AM, Horne E, Harmon M, Carter AF, Hinson WH, Mirlohi S, Duncan SE, Dietrich AM, Lesser GJ.

Pract Radiat Oncol. 2014 Mar-Apr;4(2):130-135. doi: 10.1016/j.prro.2013.06.003. Epub 2013 Jul 25.

50.

Influenza vaccine immunogenicity in patients with primary central nervous system malignancy.

Strowd RE, Swett K, Harmon M, Carter AF, Pop-Vicas A, Chan M, Tatter SB, Ellis T, Blevins M, High K, Lesser GJ.

Neuro Oncol. 2014 Dec;16(12):1639-44. doi: 10.1093/neuonc/nou051. Epub 2014 Apr 8.

Supplemental Content

Loading ...
Support Center